Home » Business » Manufacturing
Sinopharm invests to expand share
By Feng Jianmin |
January 27, 2011, Thursday
|
Print Edition
Print Edition
SINOPHARM Group Co, China's largest drug distributor, will invest as much as 1.3 billion yuan (US$197 million) in major stakes in two units of Le Ren Tang, the largest drug retailer in Hebei Province.
Hong Kong-listed Sinopharm agreed to buy 60 percent in two units of LRT, including its distribution and retail business, according to a statement the company filed to Hong Kong stock exchange yesterday. Sinopharm will also invest 60 million yuan in LRT's distribution unit. The purchases will grow Sinopharm's market share in northern China.
"The pharmaceutical market in Hebei Province will grow at around 25 percent in 2010," said Sinopharm.
It expects rapid growth to continue as the government raises expenditure on pharmaceuticals and health care.
A new type of rural corporate medical system was unveiled in the province in 2010.
Hong Kong-listed Sinopharm agreed to buy 60 percent in two units of LRT, including its distribution and retail business, according to a statement the company filed to Hong Kong stock exchange yesterday. Sinopharm will also invest 60 million yuan in LRT's distribution unit. The purchases will grow Sinopharm's market share in northern China.
"The pharmaceutical market in Hebei Province will grow at around 25 percent in 2010," said Sinopharm.
It expects rapid growth to continue as the government raises expenditure on pharmaceuticals and health care.
A new type of rural corporate medical system was unveiled in the province in 2010.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
